1. Market Research
  2. > Pathology Industry
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

Cancer Industry, April 2017 Market Reports from Top Publishers

You might be interested in: Diagnostics, Molecular Diagnostic, Infectious Disease, Therapy, Hospital, Lung Cancer, Breast Cancer, Colorectal Cancer, In Vitro Diagnostic Reagent, Computed Tomography, Cancer Diagnostic, Biopsy, Pharmaceutical, Prostate Cancer, Magnetic Resonance Imaging, Cervical Cancer, Bladder Cancer, Pancreatic Cancer, Healthcare, Point Of Care Testing.


 
1-10 of about 2900 reports for Cancer

Purchase Reports From Reputable Market Research Publishers

United States Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022

United States Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022

  • $ 1190
  • Industry report
  • April 2017
  • by Igate Research

The unprecedented demand of proton therapy for the treatment of cancer has set the stage for the market to move ahead at a rapid pace. Proton therapy is an advanced form of radiation therapy that uses ...

Medite Cancer Diagnostics Inc

Medite Cancer Diagnostics Inc

  • $ 99
  • Company report
  • April 2017
  • by Wright Investors' Service

A textual analysis of the financial results for Medite Cancer Diagnostics Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

The 2018-2023 World Outlook for Non-hematological Cancer Treatments

The 2018-2023 World Outlook for Non-hematological Cancer Treatments

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for non-hematological cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ...

The 2018-2023 World Outlook for Cancer Diagnostics

The 2018-2023 World Outlook for Cancer Diagnostics

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ...

The 2018-2023 World Outlook for Uterine Cancer Treatments and Diagnostics

The 2018-2023 World Outlook for Uterine Cancer Treatments and Diagnostics

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for uterine cancer treatments and diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry ...

The 2018-2023 World Outlook for Lung Cancer Surgery

The 2018-2023 World Outlook for Lung Cancer Surgery

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for lung cancer surgery across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ...

The 2018-2023 World Outlook for Kidney Cancer-treating Drugs

The 2018-2023 World Outlook for Kidney Cancer-treating Drugs

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for kidney cancer-treating drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ...

The 2018-2023 World Outlook for Prostate Cancer Treatments and Prevention

The 2018-2023 World Outlook for Prostate Cancer Treatments and Prevention

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for prostate cancer treatments and prevention across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry ...

The 2018-2023 World Outlook for Gastric Cancer Drugs

The 2018-2023 World Outlook for Gastric Cancer Drugs

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for gastric cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ...

The 2018-2023 World Outlook for Gastric Cancer Monoclonal Antibodies (mAb)

The 2018-2023 World Outlook for Gastric Cancer Monoclonal Antibodies (mAb)

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for gastric cancer monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry ...

About 78000 reports for Cancer

Download Unlimited Documents from Trusted Public Sources

Cancer Statistics and Sexually Transmitted Disease Statistics in Canada and North America

  • January 2016
    142 pages
  • Cancer  

    Sexually Transm...  

  • North America  

    Canada  

View report >

Cancer Statistics

October 2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.